| __timestamp | Incyte Corporation | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 511495000 | 1777824000000 |
| Thursday, January 1, 2015 | 753751000 | 1807378000000 |
| Friday, January 1, 2016 | 1105719000 | 1732051000000 |
| Sunday, January 1, 2017 | 1536216000 | 1770531000000 |
| Monday, January 1, 2018 | 1881883000 | 2097224000000 |
| Tuesday, January 1, 2019 | 2158759000 | 3291188000000 |
| Wednesday, January 1, 2020 | 2666702000 | 3197812000000 |
| Friday, January 1, 2021 | 2986267000 | 3569006000000 |
| Saturday, January 1, 2022 | 3394635000 | 4027478000000 |
| Sunday, January 1, 2023 | 3695649000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success. Over the past decade, Takeda Pharmaceutical Company Limited and Incyte Corporation have showcased contrasting revenue trajectories. From 2014 to 2023, Takeda's revenue surged by approximately 140%, reaching a staggering 4.26 trillion in 2023. This growth reflects Takeda's strategic acquisitions and expansion into global markets.
Incyte, on the other hand, demonstrated a robust growth rate of over 620% during the same period, with revenues climbing from 511 million in 2014 to nearly 3.7 billion in 2023. This impressive rise underscores Incyte's innovation-driven approach, particularly in oncology.
While Takeda's revenue dwarfs Incyte's in absolute terms, the latter's rapid growth rate highlights its potential to become a formidable player in the pharmaceutical landscape. The missing data for 2024 suggests an opportunity for further analysis as these companies continue to evolve.
Revenue Showdown: GSK plc vs Incyte Corporation
Takeda Pharmaceutical Company Limited and BioMarin Pharmaceutical Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Takeda Pharmaceutical Company Limited vs Pharming Group N.V.
Takeda Pharmaceutical Company Limited and Incyte Corporation: SG&A Spending Patterns Compared
Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited vs Dynavax Technologies Corporation: Annual Revenue Growth Compared
Incyte Corporation or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Incyte Corporation vs Galapagos NV: Annual Revenue Growth Compared
Incyte Corporation and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis